Open AccessAripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
Author(s) -
Javier VázquezBourgon,
Víctor OrtizGarcía de la Foz,
Marcos GómezRevuelta,
Jacqueline Mayoral-van Son,
María Juncal-Ruiz,
Nathalia Garrido-Torres,
Benedicto CrespoFacorro
Publication year - 2022
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyac033
Subject(s) - aripiprazole , risperidone , antipsychotic , medicine , metabolic syndrome , weight gain , drug naïve , psychosis , psychology , schizophrenia (object oriented programming) , endocrinology , psychiatry , obesity , drug , body weight
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom